Oncotelic Therapeutics Inc (OTLC): News out. "Oncotelic Initiates Phase 1 T...

Reply Private New

Replies (2) Next 10 Prev Next

Send PM Follow Ignore

Re: None

Wednesday, 01/05/2022 9:09:25 AM

Wednesday, January 05, 2022 9:09:25 AM

News out. "Oncotelic Initiates Phase 1 Trial Evaluating CA4P in Combination with Pembrolizumab for Melanoma | OTLC - Oncotelic Therapeutics, Inc. | News | OTC Markets" https://www.otcmarkets.com/stock/OTLC/news/Oncotelic-Initiates-Phase-1-Trial-Evaluating-CA4P-in-Combination-with-Pembrolizumab-for-Melanoma?id=337839

Keep Last Read

Replies (2) Next 10 Prev Next

Form 8-K - Current report • Edgar (US Regulatory) • 02/02/2024 10:00:40 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 01:00:10 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/23/2023 02:30:16 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/18/2023 09:00:34 PM
Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 07/13/2023 01:25:06 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/13/2023 01:15:33 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/30/2023 01:25:05 PM

InvestorsHub NewsWire

Only $200 per official company press release!